secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001193125-24-069285
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Homology stockholders approve all merger-related proposals with Q32 Bio
-----------------------------------------------------------------------

- Stock Issuance Proposal passed: 35M for, 4.2M against, 9.3M broker non-votes.
- Authorized shares increased to 400M, and reverse stock split (1:10 to 1:30) approved.
- 2024 Stock Option Plan and ESPP approved; Merger compensation advisory also passed.
- Adjournment proposal approved but not needed as all key proposals passed.
- Special Meeting had 48.6M shares present (83.6% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/0001193125-24-069285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312524069285/d806902d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-069285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer